Dafodil Neo Mitral Bioprosthetic Valve

The Elgiloy alloy wireform backbone provides superior radial strength and fatigue resistance, ensuring consistent valve geometry and optimal coaptation. This translates to predictable hemodynamic performance and reduced risk of paravalvular leakage post-implantation, enhancing overall clinical outcomes.

The Anti Ca™ treatment significantly reduces calcium binding to the pericardial tissue, mitigating the risk of valve calcification and subsequent structural valve deterioration. This proprietary treatment enhances the long-term biocompatibility and durability of the bioprosthesis.

The valve's design facilitates ease of implantation with predictable seating. The Elgiloy backbone provides structural support for secure suturing. The available range of mitral sizes (23-33mm) allows for optimal sizing, reducing the risk of patient-prosthesis mismatch and improving surgical outcomes.

This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.

Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the Dafodil Neo Mitral Bioprosthetic Valve, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.

The Dafodil Neo Mitral Bioprosthetic Valve is constructed using Bovine Pericardium, ensuring high biocompatibility and durability.